Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Helena Pópulo, Beatriz Domingues, Cristina Sampaio, José Manuel Lopes & Paula Soares. (2021) Combinatorial Therapies to Overcome BRAF/MEK Inhibitors Resistance in Melanoma Cells: An in vitro Study. Journal of Experimental Pharmacology 13, pages 521-535.
Read now
Read now
Articles from other publishers (19)
Zexin Zhang, Yan He, Rongjie Lin, Junhong Lan, Yueying Fan, Peng Wang & Chiyu Jia. (2022) Identification of Important Modules and Biomarkers That Are Related to Immune Infiltration Cells in Severe Burns Based on Weighted Gene Co-Expression Network Analysis. Frontiers in Genetics 13.
Crossref
Crossref
Gennie L. Parkman, Mona Foth, David A. Kircher, Sheri L. Holmen & Martin McMahon. (2021) The role of PI3'‐lipid signalling in melanoma initiation, progression and maintenance. Experimental Dermatology 31:1, pages 43-56.
Crossref
Crossref
Yun Zhao & Changzheng Huang. (2021) The role of osteopontin in the development and metastasis of melanoma. Melanoma Research 31:4, pages 283-289.
Crossref
Crossref
Mona Foth & Martin McMahon. (2021) Autophagy Inhibition in BRAF-Driven Cancers. Cancers 13:14, pages 3498.
Crossref
Crossref
Thilo Gambichler, Konstantinos Tsagoudis, Felix Kiecker, Uwe Reinhold, Eggert Stockfleth, Rami Hamscho, Friederike Egberts, Axel Hauschild, Teresa Amaral & Claus Garbe. (2021) Prognostic significance of an 11-gene RNA assay in archival tissue of cutaneous melanoma stage I–III patients. European Journal of Cancer 143, pages 11-18.
Crossref
Crossref
Lauren G. Aoude, Vanessa F. Bonazzi, Sandra Brosda, Kalpana Patel, Lambros T. Koufariotis, Harald Oey, Katia Nones, Scott Wood, John V. Pearson, James M. Lonie, Melissa Arneil, Victoria Atkinson, B. Mark Smithers, Nicola Waddell & Andrew P. Barbour. (2020) Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients. Scientific Reports 10:1.
Crossref
Crossref
N. I. Rozhkova, V. K. Bozhenko, I. I. Burdina, S. B Zapirova, E. A. Kudinova, P. G. Labazanova, M. L. Mazo, S. Yu. Mikushin, S. P. Prokopenko & O. E. Yakobs. (2020) Radiogenomics of breast cancer as new vector of interdisciplinary integration of radiation and molecular biological technologies (literature review). Medical alphabet:20, pages 21-29.
Crossref
Crossref
Mona Foth, Gennie Parkman, Benjamin Battistone & Martin McMahon. (2020)
RAC1
mutation is not a predictive biomarker for PI3’‐kinase‐β‐selective pathway‐targeted therapy
. Pigment Cell & Melanoma Research 33:5, pages 719-730.
Crossref
Crossref
Filippo Mancuso, Sergio Lage, Javier Rasero, José Luis Díaz‐Ramón, Aintzane Apraiz, Gorka Pérez‐Yarza, Pilar Ariadna Ezkurra, Cristina Penas, Ana Sánchez‐Diez, María Dolores García‐Vazquez, Jesús Gardeazabal, Rosa Izu, Karmele Mujika, Jesús Cortés, Aintzane Asumendi & María Dolores Boyano. (2020) Serum markers improve current prediction of metastasis development in early‐stage melanoma patients: a machine learning‐based study. Molecular Oncology 14:8, pages 1705-1718.
Crossref
Crossref
Teresa M.S. Amaral, Marie-Christine Hoffmann, Tobias Sinnberg, Heike Niessner, Heiko Sülberg, Thomas K Eigentler & Claus Garbe. (2020) Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma. European Journal of Cancer 125, pages 38-45.
Crossref
Crossref
Aaron Phelan & Simon J. P. Warren. 2019. Predictive Biomarkers in Oncology. Predictive Biomarkers in Oncology
463
474
.
Carmen Rodríguez-Cerdeira, Alberto Molares-Vila, Miguel Carnero-Gregorio & Alberte Corbalán-Rivas. (2018) Recent advances in melanoma research via “omics” platforms. Journal of Proteomics 188, pages 152-166.
Crossref
Crossref
Katja PinkerJoanne ChinAmy N. MelsaetherElizabeth A. MorrisLinda Moy. (2018) Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment. Radiology 287:3, pages 732-747.
Crossref
Crossref
Andreas G. Nerlich. (2018) Molecular paleopathology and paleo-oncology–State of the art, potentials, limitations and perspectives. International Journal of Paleopathology 21, pages 77-82.
Crossref
Crossref
Anita Thyagarajan, Ahmed Shaban & Ravi Prakash Sahu. (2018) MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention. Journal of Pharmacology and Experimental Therapeutics 364:1, pages 1-12.
Crossref
Crossref
Maxim Ivanov, Konstantin Laktionov, Valery Breder, Polina Chernenko, Ekaterina Novikova, Ekaterina Telysheva, Sergey Musienko, Ancha Baranova & Vladislav Mileyko. (2017) Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions. Journal of Translational Medicine 15:1.
Crossref
Crossref
Sotirios P. Fortis, Louisa G. Mahaira, Eleftheria A. Anastasopoulou, Ioannis F. Voutsas, Sonia A. Perez & Constantin N. Baxevanis. (2017) Immune profiling of melanoma tumors reflecting aggressiveness in a preclinical model. Cancer Immunology, Immunotherapy 66:12, pages 1631-1642.
Crossref
Crossref
Mohammed Kashani-Sabet, Mehdi Nosrati, James R. MillerIIIIII, Richard W. Sagebiel, Stanley P.L. Leong, Andrew Lesniak, Schuyler Tong, Sandra J. Lee & John M. Kirkwood. (2017) Prospective Validation of Molecular Prognostic Markers in Cutaneous Melanoma: A Correlative Analysis of E1690. Clinical Cancer Research 23:22, pages 6888-6892.
Crossref
Crossref
Eun-Ok Choi, Eun-Ju Cho, Jin-Woo Jeong, Cheol Park, Su-Hyun Hong, Hye-Jin Hwang, Sung-Kwon Moon, Chang Gue Son, Wun-Jae Kim & Yung Hyun Choi. (2017) Baicalein Inhibits the Migration and Invasion of B16F10 Mouse Melanoma Cells through Inactivation of the PI3K/Akt Signaling Pathway. Biomolecules & Therapeutics 25:2, pages 213-221.
Crossref
Crossref